Protecting Encapsulin Nanoparticles with Cysteine-Knot Miniproteins.

ABSTRACT: A big hurdle for the use of protein-based drugs is that they are easily degraded by proteases in the human body. In an attempt to solve this problem, we show the possibility to functionalize TM encapsulin nanoparticles with an mEETI-II knottin miniprotein from the cysteine-stabilized knot class. The resulting particles did not show aggregation and retained part of their protease inhibitive function. This imposes a protection toward protease, in this case, trypsin, degradation of the protein cage. The used chemistry is easy to apply and thus suitable to protect other protein systems from degradation. In addition, this proof of principle opens up the use of other knottins or cysteine-stabilized knots, which can be attached to protein cages to create a heterofunctionalized protein nanocage. T

SUBMITTER: Klem R 

PROVIDER: S-EPMC6143317 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature